Your browser doesn't support javascript.
loading
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.
Chi, K N; Sandhu, S; Smith, M R; Attard, G; Saad, M; Olmos, D; Castro, E; Roubaud, G; Pereira de Santana Gomes, A J; Small, E J; Rathkopf, D E; Gurney, H; Jung, W; Mason, G E; Dibaj, S; Wu, D; Diorio, B; Urtishak, K; Del Corral, A; Francis, P; Kim, W; Efstathiou, E.
Afiliação
  • Chi KN; University of British Columbia, BC Cancer-Vancouver Center, Vancouver, Canada. Electronic address: kchi@bccancer.bc.ca.
  • Sandhu S; Peter MacCallum Cancer Center, Melbourne, Australia; University of Melbourne, Melbourne, Australia.
  • Smith MR; Massachusetts General Hospital Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.
  • Attard G; University College London Cancer Institute, London, UK; University College London Hospitals, London, UK.
  • Saad M; Department of Clinical Oncology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Olmos D; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid.
  • Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Roubaud G; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Pereira de Santana Gomes AJ; Liga Norte Riograndense Contra o Câncer, Natal, Brazil.
  • Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco.
  • Rathkopf DE; Memorial Sloan Kettering Cancer Center, New York, USA; Weill Cornell Medicine, New York, USA.
  • Gurney H; Macquarie University, Macquarie Park, Australia.
  • Jung W; Keimyung University Dongsan Hospital, Daegu, South Korea.
  • Mason GE; Janssen Research & Development, LLC, Spring House.
  • Dibaj S; Janssen Research & Development, LLC, San Diego.
  • Wu D; Janssen Research & Development, LLC, Los Angeles.
  • Diorio B; Janssen Research & Development, LLC, Titusville.
  • Urtishak K; Janssen Research & Development, LLC, Spring House.
  • Del Corral A; Janssen Research & Development, LLC, Raritan.
  • Francis P; Janssen Research & Development, LLC, Bridgewater.
  • Kim W; Janssen Research & Development, LLC, Los Angeles.
  • Efstathiou E; Houston Methodist Cancer Center, Houston, USA.
Ann Oncol ; 34(9): 772-782, 2023 09.
Article em En | MEDLINE | ID: mdl-37399894
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Clinical_trials Limite: Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article